期刊文献+

微小残留病监测在自体造血干细胞移植中的应用 被引量:2

下载PDF
导出
摘要 自体干细胞移植(autologous stem cell transplanta-tion,ASCT)是治疗血液系统恶性肿瘤的有效手段之一,但移植后较高的复发率仍是影响其疗效的主要原因。近年研究发现,
作者 李刚
出处 《临床误诊误治》 2011年第9期85-88,共4页 Clinical Misdiagnosis & Mistherapy
  • 相关文献

参考文献22

  • 1Bene M C, Kaeda J S. How and why minimal residual dis- ease studies are necessary in leukemia: a review from WP10 and WP12 of the European LeukaemiaNet [ J ]. Haematologi- ca, 2009,94(8) :1135-1150.
  • 2Kern W, Haferlach C, Haferlach T, et al. Monitoring of minimal residual disease in acute myeloid leukemia [ J ]. Cancer, 2008,112(1) : 4-16.
  • 3Campana D. Role of minimal residual disease monitoring in aduh and pediatric acute lymphoblastic leukemia [ J ]. Hema- tol Oncol Clin North Am, 2009,23(5) :1083-1098.
  • 4Pui CH, Campana D, Pei D, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation [ J ]. N En- gl J Med, 2009,360(26) : 2730-2741.
  • 5Mullighan C G, Collins-Underwood J R, Phillips L A, et al. Rearrangement of CRLF2 in B-progenitor- and Down syn- drome-associated acute lymphoblastic leukemia[J]. Nat Gen-et, 2009,41(11) :1245-1246.
  • 6Yoda A, Yoda Y, Chiaretti S. Functional screening identi- fies CRLF2 in precursor B-cell acute lymphoblastic leukemia [J]. Proc Natl Acad Sci U S A, 2010,107( 1 ) :252-257.
  • 7Schnittger S, Schoch C, Kern W. Nucleophosmin gene mu- tations are predictors of favorable prognosis in acute myeloge- nous leukemia With a normal karyotype[ J]. Blood, 2005,106 (12) :3733-3739.
  • 8Weisser M, Kern W, Rauhut S, et al. Prognostic impact of RT-PCR-based quantification of WT1 gene expression during MRD monitoring of acute myeloid leukemia [ J 1. Leukemia, 2005,19(8) :1416-1423.
  • 9Feller N, van der Pal M A, Waaijman T, et al. Immunologic purging of autologous peripheral blood stem cell products based on CD34 and CD133 expression can be effectively and safely applied in half of the acute myeloid leukemia patients [ J ]. Clin Cancer Res, 2005,11 (13) :4793-4801.
  • 10Feller N, Jansen van der Weide M C, Van der Pol M A, et al. Purging of peripheral blood stem cell transplants in AML: a predictive model based on minimal residual disease burden[J]. Exp Hematol, 2005,33( 1 ) : 120-130.

同被引文献21

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部